3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
1
Hepatitis
1
Colitis
1
Interventions
pembrolizumab
521
Specimen Handling
383
Carboplatin
376
Magnetic Resonance Spectroscopy
334
Cisplatin
331
Nivolumab
309
Cyclophosphamide
298
Radiotherapy
257
Paclitaxel
254
Biopsy
235
Gemcitabine
234
Bevacizumab
218
Dexamethasone
169
durvalumab
167
Oxaliplatin
163
Capecitabine
159
Rituximab
156
Fluorouracil
149
venetoclax
147
Docetaxel
147
atezolizumab
143
Drug Therapy
143
Etoposide
141
Doxorubicin
134
Ipilimumab
129
Prednisone
121
Radiosurgery
120
Lenalidomide
118
Leucovorin
113
fludarabine
109
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Azathioprine
×
1 year
×
Clear all
NCT07619898
2026-06-02
PHOENIX-ECP
Therakos LLC
Phase 2
Not yet recruiting
112 enrolled